Proceedings of a meeting of friends of Rev. John Pierpont : and his reply to the charges of the committee, of Hollis Street Society.

"October 26th, 1839."

A testimony from the Two Months' Meeting of Congénies : of those who profess with Friends, concerning Louis Antoine Majolier, who died at Congénies the sixth of 3rdmonth, 1842. Read in the Yearly Meeting of 1844.

Smith II:724.

Friends pamphlets from the Durrett collection, 1828-68.

No. 1. A declaration of the yearly meeting of Friends, held in Philadelphia. 1828.--no. 2. A testimony from the monthly meeting of Friends of Jericho, concerning Elias Hicks. 1830.--no. 3. An epistle of affectionate caution and counsel, addressed to its members by the yearly meeting of Friends, held in Philadelphia. 1853.--no. 4. Memorials concerning deceased Friends: members of the yearly meeting of Philadelphia. 1853.--no. 5. The constitution and first annual report of the Association of Friends for the diffusion of religious and useful knowledge. 1859.--no. 6. Memorials of deceased Friends of New England yearly meeting. 1868

Conference of all Friends held in London, August 12 to 20, 1920 : official report.

Cover title: All Friends' Conference, London, August, 1920, official report.

Facts and observations relative to the participation of American citizens in the African slave trade /

Includes bibliographical references.

A view of the present state of the African slave trade.

Mode of access: Internet.

Devotional and doctrinal extracts, from epistles of the yearly meetings in London, of the people called Quakers, from the year 1678, to 1810.

Preface signed: Philemon.

A sermon preached at the meeting house of the people called Quakers, in Grace Church Street, London, September the twenty-fifth, 1737 /

Bound with Hicks, Elias. A series of extemporaneous discourses. Philadelphia, 1825.

Proceedings of the Entomological Society of Philadelphia.

v. 1 (1861-1863)

Trends in qualifying biomarkers in drug safety. Consensus of the 2011 meeting of the spanish society of clinical pharmacology.

In this paper we discuss the consensus view on the use of qualifying biomarkers in drug safety, raised within the frame of the XXIV meeting of the Spanish Society of Clinical Pharmacology held in Málaga (Spain) in October, 2011. The widespread use of biomarkers as surrogate endpoints is a goal that scientists have long been pursuing. Thirty years ago, when molecular pharmacogenomics evolved, we anticipated that these genetic biomarkers would soon obviate the routine use of drug therapies in a way that patients should adapt to the therapy rather than the opposite. This expected revolution in routine clinical practice never took place as quickly nor with the intensity as initially expected. The concerted action of operating multicenter networks holds great promise for future studies to identify biomarkers related to drug toxicity and to provide better insight into the underlying pathogenesis. Today some pharmacogenomic advances are already widely accepted, but pharmacogenomics still needs further development to elaborate more precise algorithms and many barriers to implementing individualized medicine exist. We briefly discuss our view about these barriers and we provide suggestions and areas of focus to advance in the field.

Abstracts of communications: Proceedings of the thirty-nineth meeting of the Agricultural Research Modellers' Group

This group, which is concerned with the applications of mathematics to agricultural science, was formed in 1970 and has since met at approximately yearly intervals in London for one-day meetings. The thirty-ninth meeting of the group, chaired by Professor N. Crout of the University of Nottingham, was held in the Kohn Centre at the Royal Society, 6 Carlton House Terrace, London on Friday, 30 March 2007 when the following papers were read.